Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011
Clinical trial NCT06925919 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06925919
- Sponsor
- IDBiologics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-02
- Primary completion
- 2026-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.